There are many challenges to accessing PrEP and thus low uptake in the United States. This review (2007–2017) of PrEP implementation identified barriers to PrEP and interventions to match those barriers. The final set of articles (n = 47) included content on cognitive aspects of HIV service providers and individuals at risk for infection, reviews, and case studies. Cognitive barriers and interventions regarding patients and providers included knowledge, attitudes, and beliefs about PrEP. The “purview paradox” was identified as a key barrier—HIV specialists often do not see HIV-negative patients, while primary care physicians, who often see uninfected patients, are not trained to provide PrEP. Healthcare systems barriers included lack of communication about, funding for, and access to PrEP. The intersection between PrEP-stigma, HIV-stigma, transphobia, homophobia, and disparities across gender, racial, and ethnic groups were identified; but few interventions addressed these barriers. We recommend multilevel interventions targeting barriers at multiple socioecological domains.
World Health Organization, Clinical Guidelines Across the Continuum of Care: Linking people diagnosed with HIV infection to HIV care and treatment, in Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach June 13. 2013, World Health Organization: Geneva, Switzerland. p. 272.
CDC, High-impact HIV prevention: CDC’s approach to reducing HIV infections in the United States. 2011, Centers for Disease Control & Prevention National Center for HIV/AIDS VH, STD, and TD Prevention, Division of HIV/AIDS Prevention.
Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151. CrossRef
Wilton J, et al. Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review. HIV/AIDS (Auckland, NZ). 2015;7:125.
Liu AY, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241–7. PubMed
Castel AD, Magnus M, Greenberg AE. Pre-exposure prophylaxis for human immunodeficiency virus. Infect Dis Clin. 2014;28(4):563–83. CrossRef
Baeten JM, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;2012(367):399–410. CrossRef
Thigpen MC, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;2012(367):423–34. CrossRef
FDA, FDA approves first medication to reduce HIV risk. Silver Spring; 2012.
Strauss A, Corbin JM. Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks: Sage Publications; 1990.
Hakre S, et al. Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers. Medicine. 2016;95(32):4511. CrossRef
Shaeer KM, et al. Exploratory survey of Florida pharmacists’ experience, knowledge, and perception of HIV pre-exposure prophylaxis. J Am Pharm Assoc. 2014;54(6):610–7. CrossRef
Rowniak S. PrEP: a case study. J Am Assoc Nurse Pract. 2015;27(6):296–9. PubMed
Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016. https://doi.org/10.7448/IAS.19.7.21105.
Burda JP. PrEP and our youth: implications in law and policy. Columbia J Gender Law. 2015;30:295.
Centers for Disease Control and Prevention. PrEP. 2018; https://www.cdc.gov/hiv/basics/prep.html.
Gilead Sciences Inc. Gilead Advancing Access. 2018; https://www.gileadadvancingaccess.com/.
Nunn AS, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS (London, England). 2017;31(5):731. CrossRef
NIH. NLM Requests Quotations for 2017 HIV/AIDS Community Information Outreach Projects. 2017 June 01, 2017 March 27, 2018; https://www.nlm.nih.gov/news/nlm_rfq_hiv_aids_outreach_2017.html.
Medicine U.S.N.L.o. ClinicalTrials.gov Database. https://clinicaltrials.gov/.
US Department of Health and Human Services, Research Portfolio Online Reporting Tools (RePORT).
Metzl JM. Structural competency. Am Q. 2012;64(2):213–8. CrossRef
Hatzenbuehler ML, Link BG. Introduction to the special issue on structural stigma and health. Social Sci Med. 2014;103:1–6. CrossRef
- Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature
Rogério M. Pinto
Kathryn R. Berringer
- Springer US
- AIDS and Behavior
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254